Central nervous system biomarkers GFAp and NfL associate with post-acute cognitive impairment and fatigue following critical COVID-19

Abstract A high proportion of patients with coronavirus disease 2019 (COVID-19) experience post-acute COVID-19, including neuropsychiatric symptoms. Objective signs of central nervous system (CNS) damage can be investigated using CNS biomarkers such as glial fibrillary acidic protein (GFAp), neurofi...

Full description

Bibliographic Details
Main Authors: Lovisa Bark, Ing-Marie Larsson, Ewa Wallin, Joel Simrén, Henrik Zetterberg, Miklos Lipcsey, Robert Frithiof, Elham Rostami, Michael Hultström
Format: Article
Language:English
Published: Nature Portfolio 2023-08-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-39698-y